Mimi I. Hu, MD (she/her/hers)

Professor
University of TX MD Anderson Cancer Center
Houston, TX, United States

Dr. Mimi Hu is an oncologic endocrinologist, Professor and Chair ad interim in the Department of Endocrinology and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, Texas USA. She is the program director of the Oncologic Endocrine Fellowship program. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma with a special focus on medullary thyroid cancer and hereditary endocrine neoplasia disorders. She is the co-chair of the ATA’s Guidelines Committee for the “Update on Systemic Therapies for Medullary Thyroid Carcinoma” and the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders.

Disclosure information not submitted.

Presentation(s):

• SAT-296 - MEN2A Secondary to the RET P.K666N Pathogenic Variant: Phenotype Expression in an Increasingly Diagnosed Disease

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SY06-01 - RET-Mutated Medullary Thyroid Cancer

  Saturday, June 13, 2026
  10:45 AM - 11:15 AM CT